Katherine Eban virtually presents on the following:
This talk, based on her book Dangerous Doses, describes how weak laws and poorly-implemented regulations have allowed corrupt secondary wholesalers, and even counterfeiters, to infiltrate the U.S. drug supply. This talk can be adapted for medical professionals, drug manufacturers, pharmaceutical packagers or for any company trying to ensure that their products don’t get lost in a shadowy and lucrative grey market.
Are Generic Drugs Really Bioequivalent
Generic drugs now comprise 90% of the U.S. drug supply, and the FDA has claimed that they are interchangeable with brand-name drugs. But as patients, doctors and investigators have begun to discover, they differ – sometimes dangerously – in many ways. This talk, which will be of interest to patient and medical groups, will expose how generic drugs are actually evaluated, approved and regulated, and the hidden incentives for the companies making them to cut corners (or worse).
The Dark Side of Globalization
You may think that you see eye-to-eye with the manufacturers or partners making your products half-way around the world. But invisible country and business culture may matter more than careful contracts and routine inspections. This talk, enlivened by anecdotes, will take business and regulatory audiences into a world hidden from view: fake data, manipulated ingredients, and infestations of snakes and frogs. I can also discuss solutions for protecting ones products.
Katherine Eban is an investigative journalist, is a Fortune magazine contributor and Andrew Carnegie fellow. Her articles on pharmaceutical counterfeiting, gun trafficking, and coercive interrogations by the CIA, have won international attention and numerous awards. She has also written for Vanity Fair, the New York Times and other publications. Her work has been featured on 60 Minutes, Nightline, NPR, and other national news programs. She lectures frequently on the topic of pharmaceutical integrity.
Her second book, Bottle of Lies: the Inside Story of the Generic Drug Boom, was published in May 2019 by Ecco/HarperCollins. Based on a decade of reporting, the book takes readers deep into the overseas manufacturing plants where the majority of our low-cost generic medicine is made. It reveals endemic fraud and dire conditions in an industry where companies routinely falsify data and circumvent safe manufacturing practices to minimize cost and maximize profit.
Her first book, Dangerous Doses: a True Story of Cops, Counterfeiters and the Contamination of America’s Drug Supply, was named one of the Best Books of 2005 by Kirkus Reviews and was a Barnes & Noble Discover Great New Writers pick. Her work has also been awarded grants from the Alfred P. Sloan Foundation, the Fund for Investigative Journalism, the Alicia Patterson Foundation and the McGraw Center for Business Journalism at CUNY’s Craig Newmark Graduate School of Journalism.
Educated at Brown University and Oxford University, where she was a Rhodes Scholar, she lives in Brooklyn with her husband, two daughters and Newfoundland dog Romeo.